Mon, 15th Feb 2021 16:34
GENEVA, Feb 15 (Reuters) - The World Health Organization
(WHO) on Monday listed AstraZeneca and Oxford
University's COVID-19 vaccine for emergency use, widening access
to the relatively inexpensive shot in the developing world.
A WHO statement said it had approved the vaccine as produced
by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute
of India.
(Reporting by John Revill, John Miller, Michael Shields in
Zurich, Kate Kelland in London, Editing by William Maclean)
(Correcting company name in headline)
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...
(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...
Astrazeneca (AZN)